UK markets open in 28 minutes
NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,237.59 +36.32 (+0.21%) CRUDE OIL
82.95 +0.14 (+0.17%) GOLD FUTURES
2,330.40 -8.00 (-0.34%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,471.99 -1,866.30 (-3.50%)
Stoke Therapeutics, Inc. (STOK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 607.69M |
| Enterprise value | 408.36M |
| Trailing P/E | 21.65 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 58.43 |
| Price/book (mrq) | 3.81 |
| Enterprise value/revenue | 46.51 |
| Enterprise value/EBITDA | -3.64 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.76 |
| 52-week change 3 | 33.41% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 16.40 |
| 52-week low 3 | 3.35 |
| 50-day moving average 3 | 8.97 |
| 200-day moving average 3 | 6.13 |
Share statistics
| Avg vol (3-month) 3 | 1.21M |
| Avg vol (10-day) 3 | 1.04M |
| Shares outstanding 5 | 52.12M |
| Implied shares outstanding 6 | 51.86M |
| Float 8 | 35.46M |
| % held by insiders 1 | 4.64% |
| % held by institutions 1 | 81.16% |
| Shares short (15 Apr 2024) 4 | 5.53M |
| Short ratio (15 Apr 2024) 4 | 1.94 |
| Short % of float (15 Apr 2024) 4 | 15.98% |
| Short % of shares outstanding (15 Apr 2024) 4 | 10.61% |
| Shares short (prior month 15 Mar 2024) 4 | 3.55M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,055.89% |
Management effectiveness
| Return on assets (ttm) | -29.62% |
| Return on equity (ttm) | -60.80% |
Income statement
| Revenue (ttm) | 8.78M |
| Revenue per share (ttm) | 0.20 |
| Quarterly revenue growth (yoy) | -14.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -112.3M |
| Net income avi to common (ttm) | -104.7M |
| Diluted EPS (ttm) | -2.38 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 201.39M |
| Total cash per share (mrq) | 4.35 |
| Total debt (mrq) | 6.83M |
| Total debt/equity (mrq) | 4.28% |
| Current ratio (mrq) | 6.99 |
| Book value per share (mrq) | 3.47 |
Cash flow statement
| Operating cash flow (ttm) | -81.07M |
| Levered free cash flow (ttm) | -45.07M |
© 2024 Yahoo. All rights reserved.